当前位置:首页 - 行情中心 - 菲利华(300395) - 财务分析 - 利润表

菲利华

(300395)

  

流通市值:245.18亿  总市值:249.59亿
流通股本:5.13亿   总股本:5.22亿

利润表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、营业总收入406,260,612.771,741,811,420.381,313,558,989.73914,911,035.03
营业收入406,260,612.771,741,811,420.381,313,558,989.73914,911,035.03
二、营业总成本305,818,219.121,446,595,507.051,103,139,423.67753,013,020.33
营业成本203,311,828.941,007,255,023.5757,105,937.64522,830,043.67
税金及附加4,281,253.317,706,858.3812,137,162.318,190,511.84
销售费用4,786,224.3624,928,598.2121,297,777.7814,379,268.28
管理费用33,414,416.83146,861,537.08113,569,195.6577,054,389.58
研发费用61,356,055.48249,943,967.55197,249,976.95130,677,776.75
财务费用-1,331,559.79-100,477.671,779,373.34-118,969.79
其中:利息费用2,383,510.3613,212,132.179,548,166.536,068,445.3
其中:利息收入2,420,0289,145,228.697,070,992.234,917,742.08
加:公允价值变动收益-4,069,423.8816,518,616.2413,859,662.249,748,133.61
加:投资收益9,835,807.3911,977,137.667,660,539.464,555,389.76
资产处置收益0-2,072,082.69-1,359,591.89-1,189,872.01
资产减值损失(新)-238,021.57-20,066,357.37-3,380,125.95-2,656,360.01
信用减值损失(新)-11,317,719.98-8,388,427.39-8,293,554.16-12,332,489.54
其他收益13,144,938.0558,094,341.8348,138,290.9939,327,766.88
营业利润平衡项目0000
四、营业利润107,797,973.66351,279,141.61267,044,786.75199,350,583.39
加:营业外收入961,320.372,979,667.482,580,151.091,727,538.01
减:营业外支出159,377.829,905,471.534,292,764.92562,354.01
利润总额平衡项目0000
五、利润总额108,599,916.21344,353,337.56265,332,172.92200,515,767.39
减:所得税费用12,585,321.6218,080,666.6421,737,384.5518,587,016.61
六、净利润96,014,594.59326,272,670.92243,594,788.37181,928,750.78
持续经营净利润96,014,594.59326,272,670.92243,594,788.37181,928,750.78
归属于母公司股东的净利润105,085,733.78314,213,861.03234,645,204.36172,248,775.5
少数股东损益-9,071,139.1912,058,809.898,949,584.019,679,975.28
(一)基本每股收益0.220.610.450.33
(二)稀释每股收益0.220.610.450.33
九、综合收益总额96,014,594.59326,272,670.92243,594,788.37181,928,750.78
归属于母公司股东的综合收益总额105,085,733.78314,213,861.03234,645,204.36172,248,775.5
归属于少数股东的综合收益总额-9,071,139.1912,058,809.898,949,584.019,679,975.28
公告日期2025-04-262025-04-222024-10-222024-08-23
审计意见(境内)标准无保留意见
TOP↑